Eli Lilly Obesity Drug Poised To Blow Up Weight Loss Industry
May 7, 2023
No Comments
Tirzepatide, an Eli Lilly and Co. obesity drug approved to treat type 2 diabetes, is poised to blow up the weight loss industry.
Tirzepatide, an Eli Lilly and Co. obesity drug approved to treat type 2 diabetes, is poised to blow up the weight loss industry.
According to scientists in China, a weight loss drug like Wegovy, which is promoted by Elon Musk, has a deadly side effect that causes a person’s small intestine to become enlarged.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist medication that is used for the treatment of type 2 diabetes. It works by stimulating insulin secretion from the pancreas, as well as reducing the amount of glucose produced by the liver. Semaglutide is also thought to slow down gastric emptying, which
A company called Allurion has launched the world’s first swallowable weight loss balloon in India, which can help a user lose around 14 kg within 16 weeks with complete approval from the Central Drugs Standard Control Organization.
A new study is raising serious alarms about a popular weight-loss drug called semaglutide, found in medications like Wegovy and Ozempic. This study suggests that using semaglutide might make some people more likely to have suicidal thoughts. Here’s what you need to know: What Did the Study Find? Researchers looked
Scientists have found an easy way to lose weight. While the study’s goal was not to identify strategies to reduce weight, the data demonstrate that improving and sustaining improved sleep patterns can have a major impact.
Recent research has raised concerns about weight loss injections like semaglutide (sold as Ozempic and Wegovy), revealing a potential link to a serious eye condition called non-arteritic anterior ischemic optic neuropathy (NAION). People with diabetes on semaglutide were four times more likely to develop NAION, and those who were overweight
A groundbreaking study suggests that intermittent fasting could be more effective than standard diabetes medications for managing Type 2 diabetes. Participants who followed a 5:2 intermittent fasting diet—eating normally for five days and drastically reducing calories for two—showed significant improvements in blood sugar levels and substantial weight loss compared to
Jennifer Hyman of Rent the Runway and Deirdre Quinn of Lafayette 148 discussed with the Wall Street Journal how Ozempic users are reshaping fashion trends and boosting apparel sales. Ozempic and/or Mounjaro users are likely to sustain their weight loss if they can stay away from processed meals and obtain
